Skip to content

Detection of Asymptomatic Atrial Fibrillation in persons of 65 year of age or older

Detection of Asymptomatic Atrial Fibrillation in persons of 65 year of age or older

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25405
Enrollment
4000
Registered
2018-02-19
Start date
2018-03-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asymptomatic Atrial Fibrillation AAF AF Asymptomatisch atriumfibrilleren

Interventions

screening persons &#8805
65 years old for AAF (Asymptomatic Atrial Fibrillation)

Sponsors

Diagram B.V Dokter Stolteweg 96 8025 AZ Zwolle The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria:  -Age ≥65 years  -Is giving informed consent

Exclusion criteria

Exclusion criteria: -Known medical history with Atrial Fibrillation  -Not mental competent

Design outcomes

Primary

MeasureTime frame
Primary objective: The aim of this study is to determine the accuracy, sensitivity and specificity of the AliveCor Kardia automated AF algorithm in a transmural care setting in the Netherlands. In patients ≥65 years without symptoms associated with (A)AF.

Secondary

MeasureTime frame
Secundary objectives:  Gain insight into AAF prevalence in the Netherlands  To determine sensitivity and specificity of the AliveCor Kardia system in combination with the added expert sECG analysis findings  To determine negative predictive value of the AliveCor Kardia system  Users and patient satisfaction about AliveCor Kardia system screening  Feasibility of screening of 4000 persons ≤2 year  Feasibility of structural implementation of the AliveCor Kardia system in community care (general practitioners and other care givers)

Contacts

Public ContactIlona Kalter

Dokter Stolteweg 96

i.kalter@diagram-zwolle.nl+31 (38)4262999

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)